RXRX
Recursion Pharmaceuticals
$3.16
−$0.05 (−1.71%)Sep 10, 2026
Key metrics
The numbers that frame RXRX today
- Market cap
- $1.71B
- P/E (TTM)
- -3.3
- EV / FCF
- -3.5
- Gross margin
- 3.5%
- EV / Sales
- 22.3
- ROIC
- -300.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $2.77
- 52wk High
- $7.18
Growth
Revenue and earnings trend for RXRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RXRX
Is Recursion Pharmaceuticals a good buy?
No. Recursion Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Recursion Pharmaceuticals is selling at a very high price.
What is the market capitalization of RXRX?
Recursion Pharmaceuticals's market capitalization is $1.71B.
What is the P/E ratio for RXRX stock?
Recursion Pharmaceuticals's current P/E ratio is -3.3.
What is the 52-week high for RXRX stock?
The 52-week high for Recursion Pharmaceuticals is $7.18. The current close of $3.16 is 56% below that high.
What is the 52-week low for RXRX stock?
The 52-week low for Recursion Pharmaceuticals is $2.77. The current close of $3.16 is 14.1% above that low.
Does RXRX stock pay dividends?
Recursion Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RXRX?
Recursion Pharmaceuticals's Debt / Equity ratio is 0.07.